Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.
about
Blood Pressure in Acute Ischemic StrokeAbsolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke.Predicting a post-thrombolysis intracerebral hemorrhage: a systematic reviewThe exact science of stroke thrombolysis and the quiet art of patient selectionIntravenous Versus Intra-arterial Thrombolysis for Acute Ischemic Stroke Secondary to Basilar Artery Occlusion.Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic strokeDevelopment of a computerised decision aid for thrombolysis in acute stroke care.Diagnosis and Management of Acute Intracerebral Hemorrhage.Simple Estimates of Symptomatic Intracranial Hemorrhage Risk and Outcome after Intravenous Thrombolysis Using Age and Stroke Severity.Mechanical thrombectomy in acute ischemic stroke-experience from 6 years of practice.Opposing effects of glucose on stroke and reperfusion injury: acidosis, oxidative stress, and energy metabolism.Population-based Stroke Atlas for outcome prediction: method and preliminary results for ischemic stroke from CT.Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients.Thrombolysis risk prediction: applying the SITS-SICH and SEDAN scores in South African patients.Comparative effectiveness of standard care with IV thrombolysis versus without IV thrombolysis for mild ischemic stroke.Oxfordshire Community Stroke Project classification improves prediction of post-thrombolysis symptomatic intracerebral hemorrhageThe THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.Development of a decision analytic model to support decision making and risk communication about thrombolytic treatmentCerebral microbleeds and postthrombolysis intracerebral hemorrhage risk Updated meta-analysis.Functional Outcome of Hemorrhagic Transformation after Thrombolysis for Ischemic Stroke: A Prospective StudyIV thrombolysis in very severe and severe ischemic stroke: Results from the SITS-ISTR Registry.The role of additional computed tomography in the decision-making process on the secondary prevention in patients after systemic cerebral thrombolysis.Association between i.v. thrombolysis volume and door-to-needle times in acute ischemic stroke.Association of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post-Thrombolysis: Findings From Get With The Guidelines-Stroke.Treatment and Outcome of Thrombolysis-Related Hemorrhage: A Multicenter Retrospective StudyThe Oxfordshire Community Stroke Project classification system predicts clinical outcomes following intravenous thrombolysis: a prospective cohort study.RNA in blood is altered prior to hemorrhagic transformation in ischemic strokePrestroke Antiplatelet Effect on Symptomatic Intracranial Hemorrhage and Functional Outcome in Intravenous ThrombolysisHemorrhagic Transformation (HT) and Symptomatic Intracerebral Hemorrhage (sICH) Risk Prediction Models for Postthrombolytic Hemorrhage in the Stroke Belt.Hemorrhagic transformation after ischemic stroke in animals and humansNot only the Sugar, Early infarct sign, hyperDense middle cerebral artery, Age, Neurologic deficit score but also atrial fibrillation is predictive for symptomatic intracranial hemorrhage after intravenous recombinant tissue plasminogen activator.Clinical predictors and management of hemorrhagic transformation.Use of intravenous recombinant tissue plasminogen activator in patients outside the defined criteria: safety and feasibility issues.Intravenous thrombolysis for minor stroke and rapidly improving symptoms: a quantitative overview.Iodinated contrast prior to thrombolysis was not associated with worse intracranial hemorrhage.Safety of intravenous thrombolysis for acute ischemic stroke in specific conditions.Treatment of acute stroke: an update.Therapies for Hemorrhagic Transformation in Acute Ischemic Stroke.Alteplase Treatment in Acute Stroke: Incorporating Food and Drug Administration Prescribing Information into Existing Acute Stroke Management Guide.Intravenous thrombolysis for ischemic stroke in the golden hour: propensity-matched analysis from the SITS-EAST registry.
P2860
Q26772872-E2F9277F-50E1-473D-9163-ECD211A04FA3Q26796474-E523F1E8-EA5A-43FE-B781-3C868A717E8CQ26830834-824E80BC-FD74-4398-B28E-0D327EC72D00Q27011873-5492B561-9CDE-4361-B0CA-8E37FAE71277Q30413702-F4DB951E-D4E3-46A8-929D-FDF14DB53D58Q30414441-577F3CE6-015F-4BED-9838-78F152889227Q30620347-B0526284-D600-4C2D-BF12-9A4ECEDD027AQ31136660-50A95C3C-7164-4EB2-A8EA-7CFB26629C16Q33783574-A5FF3651-C0A4-4F39-9912-6AA7BD94CE81Q33804902-C955D89C-145C-47F1-A900-CDB4E07AA9F1Q33917117-1C4A2881-C03B-44E6-BB70-26E783BC3583Q34046584-DB011634-9204-4D2E-9D51-021553AD2CE9Q34150522-73CF088F-925B-45B2-8B4A-2CD0E0046BAEQ34561985-EB96253D-B651-48F8-A0B5-4E08CE7AF03CQ35088083-EE9325EA-2616-46EB-A877-110E15249A07Q35104807-06DB9F2E-5240-44B4-A127-16C29163373FQ35209739-AC0361C6-A8B3-4C1F-A57D-8A6D86ADA457Q35839054-F56E0242-2507-4C86-9DF8-4B0581600E90Q36052933-64A5110F-F6F5-4AF4-B696-8BDBA8B427C2Q36325806-DF199F54-38AC-49E1-A190-A9DC004D1599Q36405870-27111FCF-E30B-4290-8D37-D176B31C0193Q36412737-FA700656-049B-4CF8-9236-223E8D64B811Q36783857-32F7BC78-6AFE-449A-A40E-2D385A1F4AE4Q36835905-D7B19AF7-9F35-4B24-9303-5DB2A6E784EEQ36838308-A92C1764-A665-48A2-8047-779F999E181CQ37070899-B548C3DA-9815-4D21-8660-31A260C5218EQ37118070-C9B55B45-1EE2-41D0-992D-B8F1C8EDBC6EQ37343410-D7724711-8DAB-4F5F-909F-C035B51279FBQ37551666-E5E14317-3CBA-42CB-AE83-8F9240BE5350Q37559355-185A394B-AF9C-46D2-8465-642EBD0B184EQ37579315-513691CF-00B4-4AC2-8B4F-3DAB9D67B15FQ38074569-9EEC3245-86CD-4FE5-8B4D-00FE698C7437Q38078028-AEDC8A5F-B1BC-4373-8F3C-2425B023C99FQ38234091-763591B4-3CEF-4ECC-BA5A-F5D5C5B27430Q38366742-2C069558-523B-4806-93F9-E40EADDD0471Q38407477-C3999B8A-75E8-4EAC-9C3E-650AA102B2F0Q38541197-675000E2-2977-448D-8F16-AB3518088E69Q38764867-E61B6317-E824-483F-987E-9DF332BCFDB4Q38882193-5D03BD42-9633-4C0B-B472-D2770CD6D59BQ38896148-B5EEEC8F-DE29-4ED9-BA5C-6F5BE22D47DB
P2860
Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Predicting the risk of symptom ...... erebral hemorrhage risk score.
@en
Predicting the risk of symptom ...... tation of Treatments in Stroke
@nl
type
label
Predicting the risk of symptom ...... erebral hemorrhage risk score.
@en
Predicting the risk of symptom ...... tation of Treatments in Stroke
@nl
prefLabel
Predicting the risk of symptom ...... erebral hemorrhage risk score.
@en
Predicting the risk of symptom ...... tation of Treatments in Stroke
@nl
P2093
P1433
P1476
Predicting the risk of symptom ...... erebral hemorrhage risk score.
@en
P2093
Danilo Toni
Gary A Ford
José A Egido
Kennedy R Lees
Michael Mazya
Nils Wahlgren
Robert Mikulik
SITS Investigators
P304
P356
10.1161/STROKEAHA.111.644815
P407
P50
P577
2012-03-22T00:00:00Z